An India-made, low-cost, point of care (POC) test to detect certain life-threatening blood related genetic disorders ...

Chandrapur (Maharashtra): An India-made, low-cost, point of care (POC) test to detect certain life-threatening blood related genetic disorders including Hemophilia that enables even rural ...

New effort to address rare genetic conditions that dramatically raise the risk of serious mental health challenges, including ...

It was found that those with severe hemophilia B have less than 1% of normal factor IX activity, often experiencing spontaneous bleeding that can cause joint damage or life-threatening events.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

In a 13-year follow-up by St. Jude Children’s Research Hospital and University College London published in The New England ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's ...

Hemophilia A Market Trends The report provides a detailed analysis of the current hemophilia A marketed drugs and late-stage pipeline drugs ...

Early diagnosis allows for timely preventive treatment and reduces the need for intensive factor replacement therapy in hemophilia A children.